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 Abstract 
 
 
Background
There is increasing evidence for a link between cerebrovascular disease and 
depression in the elderly but the mechanisms are still unknown. This study examines 
the longitudinal relationship between depression and white matter lesions (WML) in a 
sample of elderly aged 65 years and over.  
 
Methods 
3C-Dijon is a 4-year follow-up population-based prospective study of 1658 subjects. 
At baseline, lifetime Major Depressive Episode diagnosis was established using "Mini 
International Neuropsychiatric Interview". At each study wave, severity of depressive 
symptoms was assessed using Center for Epidemiological Studies-Depression 
(CES-D) and antidepressants intake was recorded. At baseline, "lifetime major 
depression" (LMD) was defined as lifetime Major Depressive Episode or 
antidepressant medication intake. At follow-up, subjects were classified “incident 
depression” if scoring high at CES-D or antidepressant users. 
A baseline, cerebral MRI was performed in order to quantify WML volumes using an 
automated method of detection. At 4-year follow-up, 1214 subjects had a second 
MRI.  
 
Results 
Cross-sectional analysis showed a significantly higher WML volume in subjects with 
LMD compared to the others. Adjusted longitudinal analysis showed that increase in 
WML load was significantly higher in subjects with baseline LMD (2.1 cm3 vs. 1.5 
cm3, p=0.004). Among subjects free of depression up to baseline (n=956), the higher 
the baseline WML volume, the higher the risk of developing depression during follow-
up (OR per one quartile increase=1.3 (95% CI=1.1-1.7)). 
 
Conclusions 
Our data show that depression and WML volumes are strongly related. These results 
are consistent with the hypothesis of a vascular depression in the elderly.  
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 Introduction 
Major depression in elderly subjects is a severe and frequent psychiatric disorder 
with prevalence in the community-dwelling ranging between 1% and 5% (1). Recent 
studies suggest that a type of depression might be specific of old age, occurring 
more frequently after the age of 65 and associated with a strong vascular component 
(2-6). The vascular depression hypothesis suggests that cerebrovascular pathologies 
might predispose, precipitate, or perpetuate the development of geriatric depressive 
syndromes. However, the mechanisms that link cerebrovascular risk factors to 
depression are still unknown. The dominant interpretation is that subclinical 
cerebrovascular disease disrupts fronto-subcortical function, which in turn causes a 
syndrome of late-onset depression (4,7). With recent progress in medical imaging, it 
is possible to study simultaneously vascular factors and brain changes visible at MRI 
in relation to depression. To date, only a few studies have investigated the relation 
between cerebral white matter lesions (WML), the most common form of vascular 
brain modifications, and depression in the elderly (8-16). Most of those studies have 
reported an association between greater WML volumes and depression (8-15). 
However, the relationship between WML load and depression has never been 
investigated prospectively. 
The aim of our study was to investigate the longitudinal association between WML 
volumes and depression and to assess whether WML localization may influence this 
relationship in a large population-based sample of elderly. Furthermore, we 
investigated prospectively the association between higher WML volumes and 
incident depression risk.  
 3
H
AL author m
anuscript    inserm
-00175779, version 1
H
AL author m
anuscript    inserm
-00175779, version 1
H
AL author m
anuscript    inserm
-00175779, version 1
 Method 
Sample 
The 3C study is a multicenter cohort study, conducted in three French cities 
(Bordeaux, Dijon, and Montpellier), and designed to estimate dementia risk 
attributable to vascular factors. A sample of non-institutionalized subjects aged 65 
years and over was randomly selected from the electoral rolls of each city. Between 
January 1999 and March 2001, 9294 subjects were enrolled (Bordeaux=2104, 
Dijon=4931, and Montpellier=2259). The detailed description of the study protocol 
has been published elsewhere (17). The study protocol was approved by the Ethical 
Committee of the University Hospital of Kremlin-Bicêtre. Each participant signed an 
informed consent. Subjects were followed-up every two years during 4 years. 
Among Dijon participants aged less than 80 years old and enrolled between June 
1999 and September 2000 (N=2763), a cerebral Magnetic Resonance Imaging (MRI) 
examination was proposed. Exclusion criteria were conventional: (i) carrying a 
cardiac pacemaker, valvular prosthesis, or other internal electrical/magnetic device; 
(ii) history of neurosurgery or aneurysm; (iii) presence of metal fragments in the eyes, 
brain, or spinal cord; (iv) claustrophobia. Although 2285 subjects agreed to 
participate (82.7%), because of financial limitations, 1924 examinations were 
performed. Among subjects who had a MRI, 123 scans could not be used because of 
poor quality and a further 143 subjects were excluded because depression status 
was missing. 
Compared to the others (N=1105), subjects included in the analyses (N=1658) were 
on average significantly younger (72.5 (SD=4.1) versus 73.4 (SD=4.0), p<0.0001), 
they were less often women (62.2% versus 71.0%, p<.0001), they more often had an 
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 education level above baccalaureate (23.5% versus 17.8%, p<0.0001) and their 
health was overall better (data not shown). 
After 4-year follow-up, 1292 had a second MRI (Follow-up rate=73.7%) and the 
scans were not valid for 70 of them. Subjects without follow-up MRI (n=436) were 
older (73.5 versus 72.1, p<0.0001), they had higher prevalence of lifetime major 
depression at baseline (14.9% versus. 13.4%, P=0.04) and they had a significantly 
higher WML volume at baseline (6.4 cm3 versus. 5.3 cm3, p=0.0002). 
 
Data collected 
At each study’s wave, data were collected at the participants' home by a trained 
psychologist during a face-to-face interview using a standardized questionnaire. 
Information about demographic background, occupation, medical history, drug use 
(on a regular basis during the last month) and personal habits were collected.  
Depressive symptomatology was evaluated with the Center for Epidemiological 
Studies-Depression scale (CES-D) (18), a 20-item depression rating scale that was 
developed for use in epidemiological studies to assess frequency and severity of 
depressive symptoms experienced during the past week. High depressive 
symptomatology was defined as a CES-D score≥17 for men and ≥23 for women 
based on a validation in a French population (19). 
The Mini-International Neuropsychiatric Interview (MINI) (20) was used at baseline to 
assess the existence of lifetime major depressive episode. The MINI is a short 
structured diagnostic interview developed jointly by psychiatrists and clinicians in the 
United States and Europe, for DSM-IV and ICD-10 psychiatric disorders. With an 
administration time of approximately 15 minutes, it was designed to meet the need 
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 for a short but accurate structured psychiatric interview for clinical trials and 
epidemiological studies. 
The questionnaire included an inventory of all drugs used during the preceding 
month. To reduce underreporting, participants were asked to show medical 
prescriptions, drug packages and any other relevant information. The trade names of 
all drugs were recorded and coded using the World Health Organization Anatomical 
Therapeutic Chemical classification. Psychotropic drugs included anxiolytics, 
hypnotics and antidepressants. 
At baseline, in order to identify subjects who had lifetime major depression (LMD), we 
grouped together subjects taking antidepressants and those fulfilling lifetime major 
depressive episode criteria according to the MINI questionnaire (21). 
During subsequent waves of the 3C study (2 and 4 year follow-up), incident cases of 
depression were identified if having high depressive symptomatology (based on 
CES-D score) or taking antidepressant at least once during one of the follow-up 
examinations. 
 
MRI data 
MRI acquisition was performed on 1.5 Tesla Magnetom (Siemens, Erlangen). A 
three-dimensional (3D) high-resolution T1-weighted brain volume was acquired using 
a 3D inversion recovery fast spoiled-gradient echo sequence (3D IR-SPGR; TR = 97 
ms; TE = 4 ms; TI=600 ms; coronal acquisition). The axially reoriented 3D volume 
matrix size was 256 x 192 x 256 with a 1.0 x 0.98 x 0.98 mm3 voxel size. T2- and PD- 
(proton density) weighted brain volumes were acquired using a 2D dual spin echo 
sequence with two echo times (TR = 4400 ms; TE1 = 16 ms; TE2 = 98 ms). T2 and 
PD acquisitions consisted of 35 axial slices 3.5 mm thick (0.5 mm between slices 
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 spacing), having a 256 x 256 matrix size, and a 0.98 x 0.98 mm2 in-plane resolution. 
This relatively coarse T2/PD image axial resolution was set in order to keep 
acquisition duration in elderly subjects to a minimum. 
Positioning in the magnet was based on a common landmark for all subjects, namely 
the orbito-metal line, so that the entire brain, including cerebellum and mid-brain, was 
contained within the field of view of both the T1-weighted and T2/PD-weighted 
acquisitions. Each subject dataset (T1, T2 and PD) was readily reconstructed, 
visually checked for major artefacts, before being sent to the database repository 
(Caen) where it was archived for further analyses.  
WML volume estimation 
Fully automatic image processing software was developed to detect, measure and 
localize WML. The MR image analysis contained three major steps:  (i) Pre-
processing, including registration, non-brain tissue removal and bias field correction, 
(ii) Detection of white matter hyperintensities in T2 images including removal of false 
positives, (iii) Post-processing including generation of WML probability maps at the 
individual and sample levels, morphometry, localization and classification of WML. 
Careful inspection of initial results on several cases revealed at least two types of 
voxels wrongly classified as WML by the algorithm (false positives, FP). First, some 
FPs originated from Cerebro Spinal Fluid (CSF) / Virchow robin spaces having 
intensities similar to that of WML on T2 images. Removal of such false positives 
requested a better delineation of the CSF compartment border, which was achieved 
thanks to the SPM99 (Statistical Parametric Mapping) package. Using the high 
resolution T1 volume, an optimized CSF mask was generated, aligned on the T2 
volume using the spatial normalization matrix (SNM-1MNI), thereby allowing the 
identification and removal of WML having more than 50% of their voxels overlapping 
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 the CSF mask. Secondly, some FPs were voxels truly belonging to WM but were not 
hyperintensities. Such FPs correspond to voxels having a very low intensity but a 
larger probability to belong to the WML than to the WM class (this may happen 
because WML voxels have a larger variance than those of WM). As a consequence, 
WML having a mean T2 signal intensity lower than that of white matter were 
excluded. 
Morphological parameters were computed for each detected WML including center of 
mass coordinates, Euclidian distance to the ventricular system and principal axes 
dimension. When its distance to the ventricular system was less than 10 mm a WML 
was labeled as periventricular (PWML), otherwise it was labeled as deep (DWML).  
Stereotactic coordinates of the center of mass were calculated using the combination 
of the T1-to-PD/T2 and T1-to-Talairach space registration matrices. 
The position of the center of mass with respect to that of the major fissures and sulci 
in the Talairach atlas (interhemipsheric fissure, Rolando sulcus, Sylvian fissure, 
parieto-temporal sulcus, occipito-temporal sulcus) was then determined and used to 
define the hemispheric (left, right) and lobar (frontal, occipital temporal or parietal) 
localization of each WML. 
The volume of WML by lobe was then calculated by summing the volumes of all the 
lesions detected in each of the lobes. Similarly, a periventricular WML volume and a 
deep WML volume were estimated.  
These measures were obtained for both the baseline and the follow-up scans. The 
volume of WML detected is highly correlated to the total volume of White Matter. 
Therefore, in all the analyses, we have adjusted for White Matter volume to take that 
effect into account. 
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 For prospective analysis, WML volume was studied in four categories based on 
quartiles distribution. 
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 Covariates 
Education level was defined in four categories ranging from primary certificate level 
(low) to baccalaureate or university degree (high). Subjects were considered as 
hypertensive if systolic blood pressure (SPB) was 140 mm Hg or higher or diastolic 
blood pressure (DBP) was 90 mm Hg or higher or they were on antihypertensive 
medication.  
We defined diabetes as self-reported diabetes or fasting blood glucose  7 mmol/l. 
Subjects were considered as having a history of cardiovascular disease if they 
reported a history of stroke or myocardial infarct or arteritis. Tobacco and alcohol 
consumptions were studied in 3 classes: current, former or abstainer. 
 
Statistical analysis 
The cross-sectional analyses were performed on a sample of 1658 subjects. To 
evaluate the cross-sectional associations with WML volume and LMD prevalence, 
chi-square test was used for categorical variables and analysis of variance for 
continuous variables. For multivariate analyses, we performed analyses of 
covariance adjusting for following potential confounders (based on univariate 
analyses and literature): sex, age, hypertension, history of cardiovascular disease, 
alcohol and tobacco consumptions. Separate models were performed to analyze the 
relationship between depression and WML volumes by type or localization. 
The longitudinal association between LMD and progression of WML volumes over 4-
year follow-up was evaluated using analyses of covariance adjusting for baseline 
WML volume and delay between the two MRI examinations, in addition to the 
potential confounders listed above.  Subjects whose WML volume decreased from 
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 more than 6 cm3 (n= 8) were considered as outliers and excluded from the 
longitudinal analyses that were performed on a sample of 1214 subjects.  
In order to test the assumption that WML might cause depression, logistic regression 
model was computed to estimate the risk of developing depression during follow-up 
according to WML volumes quartile at baseline. In those analyses, subjects with LMD 
or high depressive symptoms at baseline were excluded and 959 subjects remained 
in the analyses. 
All two by two interactions were considered by adding an interaction term in the 
models but none was significant. We used SAS (release 9.1; SAS Statistical Institute, 
Cary, NC) for the analyses. 
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 Results 
The study sample at baseline is described in Table 1. Mean age of participants was 
72.4 years (Standard Deviation (SD) =4.1) and 60.6% of participants were women. 
Prevalence of LMD was 14.5% and 13.1% of subjects had high depressive 
symptoms. 
Factors associated with LMD are also shown in Table 1. LMD prevalence was higher 
in women. Mean age did not differ significantly between subjects with LMD (72.7 
years (SD=4.0)) and subjects without (72.4 years (SD=4.1)), (p=0.20). Alcohol and 
tobacco consumptions were significantly related to LMD, prevalence being higher in 
non smokers (compared to current and former smokers) as well as in former drinkers 
(compared to current and never drinkers). There was no significant trend for an 
association between LMD and education level.  
Subjects with hypertension, diabetes or history of cardiovascular disease did tend to 
have LMD more often but the associations were not significant. 
LMD prevalence was significantly higher in subjects with high depressive symptoms 
at the time of interview as well as in subjects with physical impairment. 
Mean WML volume was 5.6 cm3 (SD=5.0) at baseline and it divided up as 1.3 cm3 
(SD=3.7) in deep area, 4.3 cm3 (SD=1.0) in periventricular area. 
WML volume increased linearly with age (r=0.09, p<0.0001) and mean WML volume 
was significantly higher in subjects with hypertension (6.0 cm3 in hypertensive versus 
4.8 cm3 in normotensive subjects, p<0.0001). 
Table 2 shows the baseline cross-sectional association between WML volume and 
LMD. After adjusting for potential confounders, WML volumes were on average 
significantly higher in subjects with LMD compared to subjects without. In separate 
models by lobar volume, there was a significant association between LMD and higher 
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 WML in the frontal lobe only (p=0.01) whereas a similar but non significant trend was 
observed in the parietal lobe (p=0.12). In addition, the relationship between WML 
volume and LMD did not differ according to the type of WML (deep versus 
periventricular).  
Among the 1214 participants included in the longitudinal analyses, baseline LMD 
prevalence  was 13.8 % and baseline mean WML volume was 5.2 cm3 (SD=4.4). 
Unadjusted WML volume increase was 1.4 cm3 (SE=0.08) in subjects without 
baseline LMD and 2.1 cm3 (SE=0.20) in subjects with baseline LMD (p=0.0005). The 
WM total volume increased of 2.3 cm3 (SD=23.5) between the two MRI and did not 
differ according to baseline LMD status (p=0.12). 
Table 3 shows the adjusted longitudinal relationship between baseline LMD and 
progression of WML volume over time. After adjusting for potential confounders, 
progression of WML volume was 0.6 cm3 higher in subjects with baseline LMD 
compared to those without and this difference was significant (p=0.004). This 
association was observed whatever the localization (non significant trend for 
temporal and parietal lobes) and the type of WML.  
Exclusion of subjects who had cognitive impairment (MMSE score <24, n=64) or 
prevalent dementia (n=8), did not modify the association: progression of WML 
volume was stronger in subjects having baseline LMD (2.0 cm3, SE=0.3) compared 
to those without (1.4 cm3, SE=0.3) (p for difference=0.003). 
In additional longitudinal analyses, we tried to explore the direction of the relationship 
between WML and depression. Particularly, to test the hypothesis that high WML 
volume is a risk factor for depression, we selected a sub-sample of subjects without 
depression at baseline. Of the 956 subjects fulfilling these criteria, 103 developed a 
depression during follow-up. Table 4 shows the relationship between WML volumes 
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 at baseline and incident depression risk in subjects free of depression up to baseline 
examination. We observe that the higher the baseline WML volume, the higher the 
depression risk during follow-up (p for linear trend =0.01). 
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 Discussion 
In this study of elderly subjects, WML severity was associated with lifetime major 
depression. Actually, cross-sectional analyses showed that subjects with LMD had a 
mean volume of WML significantly higher than subjects without LMD. The plausibility 
of this association was strengthened by the longitudinal analyses which showed that 
the progression of WML volume over 4-year follow-up was significantly higher in 
subjects with LMD at baseline. 
Our cross-sectional findings are in line with most studies in clinically depressed 
subjects as well as with population-based studies that have reported an association 
between WML and depression (11,12). Our findings do not support the hypothesis 
that cerebrovascular risk factors could mediate the association between WML and 
depression (16). Indeed adjusting for age, hypertension or history of cardiovascular 
disease does not modify the association between WML and depression and our data 
do not either show an interaction between cerebrovascular risk factors and WML 
volume on the risk of depression. 
Our longitudinal findings are in contrast with two previous reports that were in favor of 
an absence of an association. However these researches were based on highly 
selected samples (22-23) Indeed, the PROSPER study (22) is a clinical trial including 
572 non-demented elderly aged 70 and above having an history of cardiovascular 
disease and the other report (23) is a case-control study comparing a group of 164 
depressed subjects to a group of 126 controls. Both studies had observed a cross-
sectional association between WML volume and depression but they also both found 
that change of WML volume over time was not related to baseline depression. 
When we performed separate analyses by type of WML (periventricular or deep), our 
data did not suggest differences in association between LMD and WML volumes. In 
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 the analyses of WML by lobe, cross sectional findings showed a relation between 
depression and WML volume in the frontal lobe only. Longitudinal WML data suggest 
that LMD is associated with higher increase in WML volume for frontal, occipital, 
parietal and temporal lobes although the association does not reach statistical 
significance for the last two. Other studies have suggested that the relationship 
between WML and depression is limited to WML localized in the frontal lobe (9,24) or 
in the deep white matter (11,13-14,25), but these studies were based on small 
clinical samples. It is therefore likely they did not have enough statistical power to 
detect WML volume differences between depressed and non depressed groups other 
than in areas where WML are the most frequent. Furthermore, our results support the 
hypothesis that WML could play a role in depression occurrence in this population. 
Actually, we observed that in subjects without any history of depression before 
enrolment, higher WML volumes at baseline increase the risk of developing 
depression during follow-up. 
Some limitations should be noted to our findings. Compared with the general 
population aged 65 years or over, the 3C participants have higher education and 
socio-economic levels, and they are healthier.  In addition, subjects who agreed to 
participate in the MRI substudy also have higher socio-economic conditions and are 
overall healthier than the 3C subjects who did not have an MRI examination. 
However, our analyses show that the acceptance rate was high and not associated 
with LMD prevalence at baseline. But we can not exclude that selection bias might 
affect the strength of the association between WML and depression. Another 
potential limitation relates on the use of CES-D and MINI instruments. Indeed, firstly, 
assessment of psychiatric conditions was not a primary objective of the 3C study and 
secondly in large scale studies such as ours, it is almost impossible to undertake 
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 extensive psychiatric interviews. Therefore, depression diagnosis is based on 
diagnostic tools and we can not determine whether depression can be attributed to 
exogenous or endogenous conditions.  
In addition, misclassification of depressed cases can occur as for any diagnosis tool. 
Although we can not exclude it, it is very unlikely that our findings are spurious and 
explain by differential misclassification. Misclassification would rather tend to bias the 
associations toward the null hypothesis and therefore underestimate the true 
association (26). 
In our cross sectional analyses, we defined lifetime major depression based on MINI 
questionnaire or antidepressant drug intake. One could argue that, in some elderly 
people, antidepressants are prescribed when they have dementia or cognitive 
deficits, but no depression and this could bias our findings. However, we have 
performed sensitivity analyses by excluding subjects taking antidepressants and the 
results were unchanged. Similarly, longitudinal results were unchanged after we 
excluded subjects taking antidepressants during follow-up (Mean WML volume 
progression =1.2 (SE=0.3) in subjects without MDE at baseline compared to mean 
WML volume progression=2.2 (SE=0.3) in subjects with baseline MDE, p<0.0001). 
In the 3C study, numerous clinical and socio-demographic data are recorded and in 
our analyses, we were able to take into account different potential confounders. The 
fact that the relationship between WML and depression is still significant after all 
those adjustments reinforces the plausibility of the association. In addition to the 
adjustments presented in the results section, we have performed additional analyses 
by adjusting on baseline cognitive performances (assessed by Mini-Mental State 
Examination) and the results were not modified. 
 17
H
AL author m
anuscript    inserm
-00175779, version 1
H
AL author m
anuscript    inserm
-00175779, version 1
H
AL author m
anuscript    inserm
-00175779, version 1
 Our study is the first to evaluate the progression of WML in relation to depression in 
the general population. Moreover, WML volumes were estimated using a fully 
automatic image processing software which produces reliable and reproducible 
results. The WML progression we observe over 4-year is compatible with previous 
reports (27,28). However, this method also has weaknesses. For around 10 % of the 
sample, WML volume decreased between baseline and 4-year follow-up MRI 
examinations. This could be artefactual or reflect brain shrinkage for some 
individuals. We have performed a sensitivity analysis by excluding subjects whose 
WML volume had decreased between baseline and 4-year follow-up and the 
associations between WML volumes and depression were unchanged. Other studies 
having developed automated method of WML detection have also observed the 
same pattern of decrease in WML load in a small proportion of individuals (27,28). 
This phenomenon may be due to the difficulty to identify small WML given the 
relative large thickness of the T2 images.  
Overall, our results are in adequacy with the hypothesis of vascular depression in the 
elderly (2,29,30). The vascular depression hypothesis state that lesions may 
contribute to the pathogenesis of depression. WML may disrupt neural circuits, or 
fiber tracts connecting frontal and subcortical regions, such disruption might alter the 
function of circuits involved in the mood regulation, contributing to the pathogenesis 
of depression (31).  In the 3C study, the relationship between WML volume and LMD 
was stronger in subjects with vascular risk factors but the interaction term was not 
significant. Therefore, our findings support the leading theory that emphasizes a 
vascular cause of depression in the elderly. 
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 In summary, this is the first longitudinal population based-study investigating the 
relationship between WML volume and WML volume change and depression in the 
elderly.  
In this large longitudinal study in a community sample of subjects aged 65 years and 
over, we demonstrate that subjects having lifetime major depression have 
significantly higher WML volumes and their WML volume increase is significantly 
higher over 4-year follow-up compared to subjects without LMD. Therefore, 
depressed subjects are at increase risk of numerous adverse outcomes including 
WML spreading and further studies are needed to understand the underlying 
mechanisms. 
In addition, higher WML volume did predict incident depression in subjects free of 
any lifetime depression up to baseline examination. These results may have some 
implications for depression prevention in older individuals but additional 
epidemiological studies are also needed to address the role of vascular risk factors 
treatment in such prevention strategy.  
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Table 1: General characteristics of the participants
All sample
N n % P†
Sex
Men 653 56 8.6 <0.0001
Women 1005 185 18.4
Education level
Low 277 49 17.7 0.25
Medium low 717 106 14.8
Medium high 314 39 12.4
High 347 45 13.0
Living alone
No 1051 130 12.4 0.001
Yes 604 110 18.2
History of cardiovascular disease‡
No 1526 221 14.5 0.83
Yes 132 20 15.1
Hypertension§
No 380 60 15.8 0.43
Lifetime major depression*
Yes 1278 181 14.2
Glycemia**
No 1454 207 14.2 0.52
High 49 8 16.3
Diabetes 142 25 17.6
Alcohol consumption
Yes 1326 170 12.8 <0.0001
No 298 60 20.1
Former 28 11 39.3
Tobacco consumption
Non smoker 1022 172 16.8 0.004
Ex smoker 549 59 10.8
Current smoker 87 10 11.5
High depressive symptoms†† 213 75 35.2 <0.0001
Physical Impairment‡‡
No 1570 221 14.1 0.01
Yes 73 18 24.7
*Lifetime major depressive episode mesured by the Mini-International Neuropsychiatric Interview (MINI) or 
use of antidepressive medication
** High defined as 6.1 mmol/l<= glycemia < 7 mmol/l, diabetes defined as reported diabete or treatment for diabete or 
glycemia >= 7 mmol/l
††Measured by the Center For Epidemiological Studies Depression Scale; defined as a score >=17 for men and >=23
for women
‡‡Measured using IADL scale
† Based on the Chi-square for qualitative variables or analysis of variance for continous variables
‡ Self reported history of stroke, arterits and myocardial infarction
§ systolic blood pressure>= 140 mm Hg and/or diastolic blood pressure >= 90 mm Hg or use antihypertensive medication
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 Table 2: Cross-sectional association between White Matter Lesions (WML) volume and lifetime major depression at baseline
P‡
Mean SE Mean SE
N
Mean  WML volume 6.8 0.50 7.6 0.54 0.03
Mean  WML volume by type
Periventricular 5.5 0.44 6.1 0.49 0.05
Deep 1.3 0.09 1.5 0.10 0.02
Mean  WML volume by lobe
Frontal 3.1 0.28 3.6 0.30 0.01
Occipital 0.7 0.03 0.7 0.04 0.48
Parietal 1.4 0.13 1.5 0.14 0.12
Temporal 1.6 0.13 1.7 0.14 0.25
SE: Standard Error
*Lifetime major depression episode measured by the Mini-International Neuropsychiatric Interview (MINI) or use of antidepressive 
medication
‡Analysis of covariance adjusting for sex, age, hypertension, history of cardiovascular disease, alcohol and tobacco
consumption, physical impaiment and brain white matter volume
 Lifetime major depression *
No Yes
(n=1417;85.5%) (n=241;14.5%)
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 Table 3: Longitudinal relationship between lifetime major depression at baseline and evolution of White Matter Lesions volume
during the 4-year follow-up
P‡
Mean SE Mean SE
N
WML volume progression 1.5 0.31 2.1 0.35 0.004
WML volume progression by type
Periventricular 1.2 0.28 1.7 0.31 0.008
Deep 0.02 0.07 0.1 0.08 0.01
WML volume progression by lobe
Frontal 0.6 0.17 0.8 0.19 0.02
Occipital 0.05 0.04 0.1 0.05 0.02
Parietal 0.3 0.10 0.4 0.11 0.06
Temporal 0.6 0.16 0.7 0.17 0.15
WML = White matter Lesions
SE: Standard Error
* Lifetime major depression episode measured by the Mini-International Neuropsychiatric Interview (MINI) or use of antidepressive medication
‡Analysis of covariance adjusting for sex, age, hypertension, history of cardiovascular disease,  alcohol and tobacco consumptions, 
 delay between MRI examination, WML volume at baseline, physical impairment and brain white matter volume
 Lifetime major depression *
No Yes
(n=1046; 86.2%) (n=168; 13.8%)
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Table 4: Relation between baseline White Matter Lesion (WML) volume and 
            the risk of incident depression* in subjects with no depression† at baseline (n=956)
WML volume percentile N
< 25th 242
25th - 50th 251
50th - 75th 237
≥ 75th 226
* defined as high depressive symptomatology or antidepressive intake
†i.e. no antidepressant, no high depressive symptomatology and no MDE at baseline
‡ Adjusted for sex, age, hypertension, history of cardiovascular disease, alcohol and tobacco
consumptions, baseline CESD score, physical impairment and brain white matter volume
2.4 (1.3-4.6)
OR (95% CI) ‡
1
1.2 (0.6-2.3)
1.5 (0.8-2.9)
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